Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Other Non-Current Liabilities (2016 - 2025)

Innovate (VATE) has 16 years of Other Non-Current Liabilities data on record, last reported at $45.0 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 5.86% year-over-year to $45.0 million; the TTM value through Sep 2025 reached $45.0 million, down 5.86%, while the annual FY2024 figure was $46.8 million, 43.41% down from the prior year.
  • Other Non-Current Liabilities reached $45.0 million in Q3 2025 per VATE's latest filing, down from $46.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $82.7 million in Q4 2023 and bottomed at $34.0 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $59.9 million, with a median of $61.7 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 672.73% in 2021, then plummeted 43.41% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $63.3 million in 2021, then grew by 12.48% to $71.2 million in 2022, then grew by 16.15% to $82.7 million in 2023, then tumbled by 43.41% to $46.8 million in 2024, then fell by 3.85% to $45.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $45.0 million in Q3 2025, $46.8 million in Q4 2024, and $47.8 million in Q3 2024.